Cardiometabolic diseases have become a leading cause of morbidity and mortality globally.
They have been tightly linked to microbiome taxonomic and functional composition, with diet …

Cardiovascular diseases (CVDs) still remain the leading concern of global health,
accounting for approximately 17.9 million deaths in 2016. The pathogenetic mechanisms of …

Previous microbiome and metabolome analyses exploring non-communicable diseases
have paid scant attention to major confounders of study outcomes, such as common, pre …

With the prevalence of cardio-metabolic disorders reaching pandemic proportions, the
search for modifiable causative factors has intensified. One such potential factor is the vast …

The discovery that gut-microbiota plays a profound role in human health has opened a new
avenue of basic and clinical research. Application of ecological approaches where the …

Millions of microbes are found in the human gut, and are collectively referred as the gut
microbiota. Recent studies have estimated that the microbiota genome contains 100-fold …

Cardiometabolic disease comprises cardiovascular and metabolic dysfunction and
underlies the leading causes of morbidity and mortality, both within the United States and …

Evidence from the literature keeps highlighting the impact of mutualistic bacterial
communities of the gut microbiota on human health. The gut microbita is a complex …

Despite milestones in preventive measures and treatment, cardiovascular disease (CVD)
remains associated with a high burden of morbidity and mortality. The protracted nature of …

Host-microbiota interactions involving inflammatory and metabolic pathways have been
linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions …